Edwards Lifesciences: Investor lunch with Dr. Gregory Fontana: June 24th in NYC

Research evidence excerpt

Edwards Lifesciences: Investor lunch with Dr. Gregory Fontana: June 24th in NYC

Deutsche Bank

Research

Rating Company Date

Buy Edwards 10 June 2026

Company Update

North America Lifesciences

United States

Reuters Bloomberg Exchange Ticker Price at 8 Jun 2026 (USD) 85.85

EW.N EW US NYS EW

Price target 100.00

Health Care

52-week range 88.16 - 72.65

Medical Supplies & Devices

Investor lunch with Dr. Gregory

Valuation & Risks Fontana: June 24th in NYC

Pito Chickering

Portfolio Manager Summary Research Analyst

Please join the DB Medtech team our investor luncheon featuring Dr. Greg Fontana, +1-917-635-9954

world-renowned CT surgeon and structural heart KOL who serves as national

Imron Zafar

director of cardiovascular services at the largest US hospital system that accounts Research Analyst

for ~10% of the US transcatheter valve (TAVR & TEER) and LAAO markets, on +1-212-250-3676

Wednesday June 24th in New York City in coincidence with the New York Valves

Kieran Ryan

meeting that week.

Research Associate

+1-212-250-6879

The focus of our discussion will be 2Q volume trends, competitive dynamics,

capacity, and LT growth outlook for key cardiovascular device markets including Ben Shaver

LAAO, PFA, TAVR, M-TEER, and TTVR/T-TEER – including implications of key clinical Research Associate

+1-212-250-9926

data readouts including CHAMPION-AF/CLOSURE-AF, long-term TAVR outcomes

from Edwards’ and Medtronic’s low-risk pivotal trials, and thoughts around

Edwards’ and Medtronic’s moderate AS trials forthcoming this fall at TCT.

Due to vacation schedules, this will be our only Fontana event in 2Q.

Seating is limited, so please reach out to a member of our team or your DB sales

representative to request a spot ASAP.

Date & Time:

Wednesday, June 24th, 12-1:30pm ET

DB Hosts: